Evidence mapPaperPMID 36243744Full record

Observational studyScientific reports2022

Dynamics of human milk oligosaccharides in early lactation and relation with growth and appetitive traits of Filipino breastfed infants.

Tinu M Samuel, Mickaël Hartweg, Jowena D Lebumfacil, Katherine B Buluran, Rachel B Lawenko, Elvira M Estorninos, Aristea Binia, Norbert Sprenger

Registry-linked trialOpen access · goldAbstract readObservational Study
In one paragraph

Observational study in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03387124 (Characterization of Stool Consistency and Fecal Microbiota of Breastfed Infants), which is not on this map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.4field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03387124 completednot on this map

Characterization of Stool Consistency and Fecal Microbiota of Breastfed Infants

TypeobservationalSponsorSociété des Produits Nestlé (SPN)Ran2018 to 2018Enrolled75ConditionsInfant Term BirthArmsBreastfed infants
3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 13 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Tinu M SamuelNestlé Product Technology Center-Nutrition, Société des Produits Nestlé S.A., 1800, Vevey, Switzerland.
Mickaël HartwegClinical Research Unit, Société des Produits Nestlé SA, 1000, Lausanne, Switzerland.
Jowena D LebumfacilClinical Research Operations, Wyeth Philippines, Inc., Makati City, 1200, Philippines.
Katherine B BuluranAsian Hospital & Medical Center, Muntinlupa City, 1780, Philippines.
Rachel B LawenkoAsian Hospital & Medical Center, Muntinlupa City, 1780, Philippines.
Elvira M EstorninosAsian Hospital & Medical Center, Muntinlupa City, 1780, Philippines.
Aristea BiniaNestlé Institute of Health Sciences, Société des Produits Nestlé SA, 1000, Lausanne, Switzerland.
Norbert SprengerNestlé Institute of Health Sciences, Société des Produits Nestlé SA, 1000, Lausanne, Switzerland. norbert.sprenger@rdls.nestle.com.
Nestlé (Switzerland) · CHAsian Hospital and Medical Center · PHNutrition Center of the Philippines · PH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Human milk oligosaccharides play a key role in the maturation of the infant gut microbiome and immune system and are hypothesized to affect growth. This study examined the temporal changes of 24 HMOs and their associations to infant growth and appetitive traits in an exploratory, prospective, observational, study of 41 Filipino mother-infant dyads. Exclusively breastfed, healthy, term infants were enrolled at 21-26 days of age (≈ 0.75 mo) and followed for 6 months. Infant growth measures and appetitive traits were collected at visit 1 (V1) (≈ 0.75 mo), V2 (≈ 1.5 mo), V3 (2.5 mo), V4 (2.75 mo), V5 (4 mo), and V6 (6 mo), while HMOs were measured at V1, V2, V3 and V5. Overall exposure to each HMO was summarized as area under the curve from baseline to 4 months of age and examined in association with each measure of growth at 6 months using linear regression adjusted for maternal age at birth, infant sex, birth weight, and mode of delivery. We saw modest associations between several HMOs and infant growth parameters. Our results suggest that specific HMOs, partly as proxy for milk groups (defined by Secretor and Lewis status), may be associated with head circumference and length, increasing their relevance especially in populations at the lower end of the WHO growth curve. We did not identify the same HMOs associated with infant appetitive traits, indicating that at least in our cohort, changes in appetite were not driving the observed associations between HMOs and growth.Clinical trial registration: NCT03387124.

Indexed as

Breast FeedingMilk, HumanFemaleHumansInfantInfant, NewbornLactationOligosaccharidesProspective StudiesOligosaccharides

Identifiers

PMID36243744
PMCPMC9569346
OpenAlexW4306291754

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.